Orphan receptor DAX-1 is a shuttling RNA binding protein associated with polyribosomes via mRNA

Molecular and Cellular Biology

Volumn 20, Issue 13, 2000, Pages 4910-4921

  Lalli, Enzo ^a   Ohe, Kenji ^a   Hindelang, Colette ^a   Sassone Corsi, Paolo ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RECEPTOR; RNA BINDING PROTEIN;

ADRENAL CORTEX; ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELL STRAIN COS1; CONTROLLED STUDY; CYTOPLASM; GENE; GENE MUTATION; HUMAN; HUMAN CELL; HYPOPLASIA; LEPIDOPTERA; LEYDIG CELL; MOUSE; NONHUMAN; POLYSOME; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN RNA BINDING;

ADRENAL CORTEX; ADRENAL HYPERPLASIA, CONGENITAL; ANIMALS; BINDING SITES; CELL LINE; CELL NUCLEUS; CYTOPLASM; DNA-BINDING PROTEINS; HUMANS; HYPOGONADISM; LEYDIG CELLS; MALE; MICE; MUTATION; POLY A; POLYRIBOSOMES; PROTEIN BIOSYNTHESIS; RECEPTORS, RETINOIC ACID; REPETITIVE SEQUENCES, AMINO ACID; REPRESSOR PROTEINS; RIBONUCLEOPROTEINS; RNA, MESSENGER; RNA-BINDING PROTEINS; TEMPERATURE; TESTICULAR NEOPLASMS; TRANSCRIPTION FACTORS;

EID: 0034083153     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.13.4910-4921.2000     Document Type: Article

References (55)

1. Bae, D. S., M. L. Schaefer, B. W. Partan, and L. Muglia. 1996. Characterization of the mouse DAX-1 gene reveals evolutionary conservation of a unique amino-terminal motif and widespread expression in mouse tissue. Endocrinology 137:3921-3927.
2. Bardoni, B., E. Zanaria, S. Guioli, G. Floridia, K. C. Worley, G. Tonini, E. Ferrante, G. Chiumello, E. R. B. McCabe, M. Fraccaro, O. Zuffardi, and G. Camerino. 1994. A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nat. Genet. 7:497-501.
3. Bernhard, W. 1969. A new staining procedure for electron microscopical cytology. J. Ultrastruct. Res. 27:250-265.
4. Bertrandy, S., P. Burlet, O. Clermont, C. Huber, C. Fondrat, D. Thierry-Mieg, A. Munnich, and S. Lefebvre. 1999. The RNA-binding properties of SMN: deletion analysis of the zebrafish orthologue defines domains conserved in evolution. Hum. Mol. Genet. 8:775-782.
5. Caricasole, A., A. Duarte, S. H. Larsson, N. D. Hastie, M. Little, G. Holmes, I. Todorov, and A. Ward. 1996. RNA binding by the Wilms tumor suppressor zinc finger proteins. Proc. Natl. Acad. Sci. USA 93:7562-7566.
6. Chambon, P. 1996. A decade of molecular biology of retinoic acid receptors. FASEB J. 10:940-954.
7. Chong, M. T., and M. E. Lippman. 1982. Effects of RNA and ribonuclease on the binding of estrogen and glucocorticoid receptors from MCF-7 cells to DNA-cellulose. J. Biol. Chem. 257:2996-3002.
8. + RNA in actively translating polyribosomes. Hum. Mol. Genet. 6:1465-1472.
9. Cusack, S. 1999. RNA-protein complexes. Curr. Opin. Struct. Biol. 9:66-73.
10. Feng, Y., C.-A. Gutekunst, D. E. Eberhart, H. Yi, S. T. Warren, and S. M. Hersch. 1997. Fragile X mental retardation protein: nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J. Neurosci. 17:1539-1547.
11. Feng, Y., D. Absher, D. E. Eberhart, V. Brown, H. E. Malter, and S. T. Warren. 1997. FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association. Mol. Cell 1:109-118.
12. Gaub, M.-P., C. Rochette-Egly, Y. Lutz, S. Ali, H. Matthes, I. Scheuer, and P. Chambon. 1992. Immunodetection of multiple species of retinoic acid receptor α: evidence for phosphorylation. Exp. Cell Res. 201:335-346.
13. Görlach, M., C. G. Burd, and G. Dreyfuss. 1994. The determinants of RNA-binding specificity of the heterogeneous nuclear ribonucleoprotein C proteins. J. Biol. Chem. 269:23074-23078.
14. Green, S., I. Issemann, and E. Scheer. 1988. A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res. 16:369.
15. Ikeda, Y., A. Swain, T. J. Weber, K. E. Hentges, E. Zanaria, E. Lalli, K. Tamai, P. Sassone-Corsi, R. Lovell-Badge, G. Camerino, and K. L. Parker. 1996. Steroidogenic factor 1 and DAX-1 colocalize in multiple cell lineages: potential links in endocrine development. Mol. Endocrinol. 10:1261-1272.
16. Ito, M., R. Yu, and J. L. Jameson. 1997. DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol. Cell. Biol. 17:1476-1483.
17. Izaurralde, E., and I. M. Mattaj. 1995. RNA export. Cell 81:153-159.
18. Kennedy, D., T. Ramsdale, J. Mattick, and M. Little. 1996. An RNA recognition motif in WT1 revealed by structural modelling. Nat. Genet. 12:329-332.
19. Ladomery, M. 1997. Multifunctional proteins suggest connections between transcriptional and post-transcriptional processes. BioEssays 19:903-909.
20. Lalli, E., B. Bardoni, E. Zazopoulos, J.-M. Wurtz, T. M. Strom, D. Moras, and P. Sassone-Corsi. 1997. A transcriptional silencing domain in DAX-1 whose mutation causes adrenal hypoplasia congenita. Mol. Endocrinol. 11: 1950-1960.
21. Lalli, E., M. H. Melner, D. M. Stocco, and P. Sassone-Corsi. 1998. DAX-1 blocks steroid production at multiple levels. Endocrinology 139:4237-4243.
22. Lalli, E., and P. Sassone-Corsi. 1999. DAX-1 and the adrenal cortex. Curr. Opin. Endocrinol. Diabetes 6:185-190.
23. Lanz, R. B., N. J. McKenna, S. A. Onate, U. Albrecht, J. Wong, S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley. 1999. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 97:17-27.
24. Liang, T., and S. Liao. 1974. Association of the uterine 17β-estradiol-receptor complex with ribonucleoprotein in vitro and in vivo. J. Biol. Chem. 249:4671-4678.
25. Liao, S., S. Smythe, J. L. Tymoczko, G. P. Rossini, C. Chen, and R. A. Hiipakka. 1980. RNA-dependent release of androgen- and other steroid-receptor complexes from DNA. J. Biol. Chem. 255:5545-5551.
26. Mangelsdorf, D. J., C. Thummel, M. Beato, P. Herrlich, G. Schütz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, and R. M. Evans. 1995. The nuclear receptor superfamily: the second decade. Cell 83:835-839.
27. Matsushima, Y., K. Matsumura, and Y. Kitagawa. 1997. Zinc finger-like motif conserved in a family of RNA binding proteins. Biosci. Biotechnol. Biochem. 61:905-906.
28. Mehlin, H., B. Daneholt, and U. Skoglund. 1992. Translocation of a specific premessenger ribonudeoprotein particle through the nuclear pore studied with electron microscope tomography. Cell 69:605-613.
29. Michael, W. M., M. Choi, and G. Dreyfuss. 1995. A nuclear export signal in hnRNP A1: a signal-mediated, temperature-dependent nuclear protein export pathway. Cell 83:415-422.
30. Moog-Lutz, C., C. Tomasetto, C. H. Régnier, C. Wendling, Y. Lutz, D. Muller, M.-P. Chenard, P. Basset, and M.-C. Rio. 1997. MLN64 exhibits homology with the steroidogenic acute regulatory protein (StAR) and is over-expressed in human breast carcinomas. Int. J. Cancer 71:183-191.
31. Nachtigal, M. W., Y. Hirokawa, D. L. Enyeart-VanHouten, J. N. Flanagan, G. D. Hammer, and H. A. Ingraham. 1998. Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell 93:445-454.
32. Nuclear Receptors Nomenclature Committee. 1999. A unified nomenclature system fur the nuclear receptor superfamily. Cell 97:161-163.
33. Piñol-Roma, S., and G. Dreyfuss. 1992. Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm. Nature 355:730-732.
34. γ ligand-binding domain and crystallization of its complex with all-trans retinoic acid. Biochem. Biophys. Res. Commun. 230:293-296.
35. Rochette-Egly, C., M. Oulad-Abdelghani, A. Staub, V. Pfister, I. Scheuer, P. Chambon, and M.-P. Gaub. 1995. Phosphorylation of the retinoic acid receptor-alpha by protein kinase A. Mol. Endocrinol. 9:860-871.
36. Rossignol, M., I. Kolb-Cheynel, and J.-M. Egly. 1997. Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH. EMBO J. 16:1628-1637.
37. Shamoo, Y., N. Abdul-Manam, and K. R. Williams. 1995. Multiple RNA binding domains (RBDs) just don't add up. Nucleic Acids Res. 23:725-728.
38. Shastry, B. S. 1996. Transcription factor IIIA (TFIIIA) in the second decade. J. Cell Sci. 109:535-539.
39. Siomi, H., M. C. Siomi, R. L. Nussbaum, and G. Dreyfuss. 1993. The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. Cell 74:291-298.
40. Stutz, F., and M. Rosbash. 1998. Nuclear RNA export. Genes Dev. 12:3303-3319.
41. Swain, A., E. Zanaria, A. Hacker, R. Lovell-Badge, and G. Camerino. 1996. Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function. Nat. Genet. 12:404-409.
42. Swain, A., V. Narvaez, P. Burgoyne, G. Camerino, and R. Lovell-Badge. 1998. Dax1 antagonizes Sry action in mammalian sex determination. Nature 391: 761-767.
43. Swain, A., and R. Lovell-Badge. 1999. Mammalian sex determination: a molecular drama. Genes Dev. 13:755-767.
44. Swanson, S. M., and G. Dreyfuss. 1988. Classification and publication of proteins of heterogeneous nuclear ribonucleoprotein particles by RNA-binding specificities. Mol. Cell. Biol. 8:2237-2241
45. Tamai, K. T., L. Monaco, T.-P. Alastalo, E. Lalli, M. Parvinen, and P. Sassone-Corsi. 1996. Hormonal and developmental regulation of DAX-1 expression in Sertoli cells. Mol. Endocrinol. 10:1561-1569.
46. Tamanini, F., C. Bontekoe, C. E. Bakker, L. van Unen, B. Anar, R. Willemsen, M. Yoshida, H. Galjaard, B. A. Oostra, and A. T. Hoogeveen. 1999. Different targets for the fragile X-related proteins revealed by their distinct nuclear localizations. Hum. Mol. Genet. 8:863-869.
47. Varani, G., and K. Nagai. 1998. RNA recognition by RNP proteins during RNA processing. Annu. Rev. Biophys. Biomol. Struct. 27:407-445.
48. Visa, N., A. T. Alzhanova-Ericsson, X. Sun, E. Kiseleva, B. Björkroth, T. Wurtz, and B. Daneholt. 1996. A pre-mRNA-binding protein accompanies the RNA from the gene through the nuclear pores and into polysomes. Cell 84:253-264.
49. Wurtz, J.-M., W. Bourguet, J.-P. Renaud, V. Vivat, P. Chambon, D. Moras, and H. Gronemeyer. 1996. A canonical structure for the ligand-binding domain of nuclear receptors. Nat. Struct. Biol. 3:87-94. (Erratum, 3:206.)
50. Xu, L., C. K. Glass, and M. G. Rosenfeld. 1999. Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev. 9:140-147.
51. Yamashita, S. 1998. Localization and functions of steroid hormone receptors. Histol. Histopathol. 13:255-270.
52. Yu, R. N., M. Ito, T. L. Saunders, S. A. Camper, and J. L. Jameson. 1998. Role of Ahch in gonadal development and gametogenesis. Nat. Genet. 20: 353-357.
53. Zanaria, E., F. Muscatelli, B. Bardoni, T. M. Strom, S. Guioli, W. Guo, E. Lalli, C. Moser, A. P. Walker, E. R. B. McCabe, T. Meitinger, A. P. Monaco, P. Sassone-Corsi, and G. Camerino. 1994. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 372:635-641.
54. Zazopoulos, E., E. Lalli, D. M. Stocco, and P. Sassone-Corsi. 1997. DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature 390:311-315.
55. Zhang, Y.-H., W. Guo, R. L. Wagner, B.-L. Huang, L. McCabe, E. Vilain, T. P. Burris, K. Anyane-Yeboa, A. H. M. Burghes, D. Chitayat, A. E. Chudley, M. Genel, J. M. Gertner, G. J. Klingensmith, S. N. Levine, J. Nakamoto, M. I. New, R. A. Pagon, J. G. Pappas, C. A. Quigley, I. M. Rosenthal, J. D. Baxter, R. J. Fletterick, and E. R. B. McCabe. 1998. DAX1 mutations map to putative structural domains in a deduced three-dimensional model. Am. J. Hum. Genet. 62:855-864.